cytarabine has been researched along with oxidopamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheung, NK; Exelby, PR; Gulati, SC; Kushner, BH; Kwon, JH; O'Reilly, RJ | 1 |
Lehtonen, S; Männistö, PT; Puttonen, KA; Raasmaja, A | 1 |
Lampela, P; Lehtonen, S; Männistö, PT; Puttonen, KA; Raasmaja, A | 1 |
Andersson, A; Dannaeus, K; Delfani, K; Di Monte, DA; Haegerstrand, A; Häggblad, J; Hill, MP; Isacson, R; Janson Lang, AM; McCormack, AL; Nielsen, E; Palmer, T; Patrone, C; Rönnholm, H; Wikstrom, L; Zachrisson, O; Zhao, M | 1 |
4 other study(ies) available for cytarabine and oxidopamine
Article | Year |
---|---|
High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dianhydrogalactitol; Doxorubicin; Female; Fluorouracil; Humans; Hydroxydopamines; Hydroxyurea; Infant; Male; Melphalan; Neoplasm Staging; Neuroblastoma; Oxidopamine; Prognosis; Radiotherapy Dosage; Remission Induction; Survival Rate; Vincristine; Whole-Body Irradiation | 1991 |
A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine.
Topics: Actins; Blotting, Western; Cell Line; Cell Survival; Cytarabine; Dipeptides; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Oxidopamine; Prolyl Oligopeptidases; Protease Inhibitors; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Pyrrolidines; Reactive Oxygen Species; Serine Endopeptidases; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53 | 2006 |
Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Death; Cell Line; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cytarabine; Dose-Response Relationship, Drug; Haplorhini; Humans; Oxidopamine; Rabbits; Rats; Toxicity Tests | 2008 |
Restorative effects of platelet derived growth factor-BB in rodent models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiogenesis Inducing Agents; Animals; Becaplermin; Cell Proliferation; Cytarabine; Disease Models, Animal; Drug Administration Schedule; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neurotoxins; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |